La Oficina de Patentes y Marcas de Estados Unidos ha concedido la Patente Nº 12.209.677, que se refiere a avances en la tecnología patentada de balón de Allurion, mejorando específicamente la ...
El estudio reveló que más de la mitad de los participantes tratados con el Balón Allurion lograron una pérdida de peso significativa a las 48 semanas. El ensayo AUDACITY, el primero en su tipo ...
At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects Low rate of serious adverse events supports favorable ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...
Allurion Technologies (ALUR) announced topline results from the AUDACITY FDA pivotal trial evaluating the safety and efficacy of the Allurion Balloon. The AUDACITY trial is an open-label ...
NATICK, Mass., January 08, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced topline results from the AUDACITY Food & Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback